Interv Akut Kardiol. 2019;18(2):99-101 | DOI: 10.36290/kar.2019.027

How to increase the effectivity of the endovascular therapy of the ischemic stroke in the Czech Republic

Antonín Krajina1, Dagmar Krajíčková2
1 Radiologická klinika LF a FN Hradec Králové
2 Neurologická klinika LF a FN Hradec Králové

The authors present an overview of the trend in endovascular procedure rates for ischemic stroke during the last six years. Mechanical thrombectomy (MT) gained the highest level of evidence in 2015 when positive results of several studies comparing the clinical outcome of MT with intravenous thrombolysis using recombinant tissue plasminogen activator were published. MT has become the most frequent endovascular therapeutic procedure on cerebral vessels. In order to provide this therapy, there has been an active geographical system of qualified cerebrovascular centers at two levels in the Czech Republic since 2010. The authors give a survey of possibilities how to increase the effectiveness of the existing system in terms of both quantitative and qualitative aspects.

Keywords: ischemic stroke, mechanical thrombectomy, stent-retriever, neurointerventions

Published: May 2, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krajina A, Krajíčková D. How to increase the effectivity of the endovascular therapy of the ischemic stroke in the Czech Republic. Interv Akut Kardiol. 2019;18(2):99-101. doi: 10.36290/kar.2019.027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Krajina A, Krajíčková D. Endovaskulární rekanalizace a zrychlení diagnostiky vede ke zlepšení výsledku léčby akutních ischemických cévních mozkových příhod. Čas Lék čes 2018; 157: 188-194.
    2. Berkhemmer OA, Fransen PS, Beumer D, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20. Go to original source... Go to PubMed...
    3. Saver JL, Goyal M, van der Lught A, et al; for the HERMES Collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis. JAMA 2016; 316(12): 1279-1288. Go to original source... Go to PubMed...
    4. Péče o pacienty s akutní cévní mozkovou příhodou. Věstník MZČR 2012, částka 10.
    5. Doporučení pro rekanalizační léčbu akutního mozkového infarktu - verze 2016. Ces Slov Neurol N 2016; 79/112(2): 231-234.
    6. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke 2018; 49: 1-65. Go to original source... Go to PubMed...
    7. Krajina A, Roček M, Köcher M, et al. Vývoj počtu endovaskulárních neurointervenčních metod v České republice v letech 2013-2016. Ces Radiol 2017; 71(2): 110-115.
    8. Aguiar de Souza D. von Martial R, Abillera S, et al.; on behalf of the ESO ESMINT EAN SAFE Survey on Stroke Care collaborators. Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. Eur Stroke J 2018 EPub July 20, 2018. https://journals.sagepub.com/doi/pdf/10.1177/2396987318786023
    9. Krajíčková D, Krajina A, Vítková E, et al. Zabezpečí současná logistika nemocným s akutním uzávěrem velké tepny v přední cirkulaci stejnou šanci na dobrý výsledek? Ces Slov Neurol N 2018; 81/114(3): 338-344. Go to original source...
    10. Fiehler J. The time-reset effect. Thrombectomy trials challenge the existence of a time window. Clin Neuroradiol 2017; 27: 3-5. Go to original source... Go to PubMed...
    11. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion Imaging. N Engl J Med 2018; 378: 708-718 Go to original source... Go to PubMed...
    12. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378: 11-21 Go to original source... Go to PubMed...
    13. Jadhav A P, Desa S M, Kenmuir C L, et al. Eligibility for endovascular trial enrollment in the 6 - to 24-hour time window. Stroke 2018; 49: 1015-1017. Go to original source... Go to PubMed...
    14. Saposnik G, Strbian D. Enlightenment and challenges offered by DAWN Trial (DWI or CTP assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo). Stroke 2018; 49: 498-500. Go to original source... Go to PubMed...
    15. Rinaldo L. Transfer to high-volume centers associated with reduced mortality after endovascular treatment of acute stroke. Stroke 2017; 48: 316-321. Go to original source... Go to PubMed...
    16. Köcher M, Šaňák D, Zapletalová J et al. Mechanical thrombecotmy for acute ischemic stroke in Czech Republic: Technical results form year 2016. Cardiovasc Intervent Radiol 2018; 41: 1901-1908. Go to original source... Go to PubMed...
    17. Volný O, Krajina A, Belasková S, et al. Mechanical thrombectomy performs similarly in real world practice: a 2016 nationwide study from the Czech Republic. J Neurointervent Surg 2018; 10(8): 741-745. Go to original source... Go to PubMed...
    18. Fischer U, Aguiar de Sousa D, Norrving B, Caso V. Status and perspectives of acute stroke care in Europe. Stroke 2018; 49: 2281-2282. Go to original source... Go to PubMed...
    19. Bendszus M, Bonekamp S, Berge E, et al. A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. Int J Stroke 2019; 14(1): 87-93. Go to original source... Go to PubMed...
    20. Van Overhagen H, van Zwam WH, Krajina A, et al. CIRSE position statement: Interventional radiologist and intraarterial stroke therapy. Cardiovasc Intervent Radiol. 2018; 41: 1460-1462. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.